«Green» synthesis of metal nanoparticles. Application and future perspective.

Autor: Voloshyna, I. M.¹ i_woloschina@yahoo.com, Lastovetska, L. O.¹, Zurnadzhian, A. A.¹, Shkotova, L. V.²

Publikováno v: Biopolymers & Cell. 2023, Vol. 39 Issue 3, p170-188. 19p.

Plasma from type 1 diabetes patients promotes pro-atherogenic cholesterol transport in human macrophages.

Autor: Accacha S; Department of Pediatrics, NYU Langone Hospital Long Island, Mineola, NY, USA., Voloshyna I; Department of Medicine, NYU Langone Hospital Long Island, Mineola, NY, USA., Kasselman LJ; Hackensack Meridian Jersey Shore University Medical Center, Hackensack, NJ, USA., Mejia-Corletto J; Department of Pediatrics, NYU Langone Hospital Long Island, Mineola, NY, USA., Srivastava A; Department of Medicine, NYU Langone Hospital Long Island, Mineola, NY, USA., Renna HA; Department of Medicine, NYU Langone Hospital Long Island, Mineola, NY, USA., De Leon J; Department of Medicine, NYU Langone Hospital Long Island, Mineola, NY, USA., Levine RL; Department of Pediatrics, NYU Langone Hospital Long Island, Mineola, NY, USA., Reiss AB; Department of Medicine, NYU Langone Hospital Long Island, Mineola, NY, USA.

Publikováno v: Journal of investigative medicine : the official publication of the American Federation for Clinical Research [J Investig Med] 2024 Nov 09, pp. 10815589241296025. Date of Electronic Publication: 2024 Nov 09.

HIGH-RISK DENTAL CARIES

Autor: Voloshyna I. M., Korablin D. I.

Publikováno v: Вісник проблем біології і медицини, Vol 1, Iss 4, Pp 139-141 (2018)

Dental caries in children and adults is the main problem in present-day dentistry and becomes not only medical, but also the social problem. The social disadaptation of person is associated with the dental esthetic disorders, loss of their function a

Externí odkaz: https://doaj.org/article/432fed1d69244ca583a2c1babc7e6b64

Bacteriocins Lactobacillus -- an alternative to antimicrobial drugs.

Autor: Voloshyna, I. M.^1,2, Soloshenko, K. I.², Krasinko, V. O.², Lych, I. V.², Shkotova, L. V.³ i_woloschina@yahoo.com

Publikováno v: Biopolymers & Cell. 2021, Vol. 37 Issue 2, p85-97. 13p.

Hybrid and vaccine-induced immunity against SAR-CoV-2 in MS patients on different disease-modifying therapies.

Autor: Kister I; NYU Multiple Sclerosis Comprehensive Care Center, Department of Neurology, New York University Grossman School of Medicine, New York, New York, 10016, USA., Curtin R; Laura and Isaac Perlmutter Cancer Center and Department of Pathology, New York University Grossman School of Medicine, New York, New York, 10016, USA., Pei J; Genentech, Inc., South San Francisco, California, USA., Perdomo K; NYU Multiple Sclerosis Comprehensive Care Center, Department of Neurology, New York University Grossman School of Medicine, New York, New York, 10016, USA., Bacon TE; NYU Multiple Sclerosis Comprehensive Care Center, Department of Neurology, New York University Grossman School of Medicine, New York, New York, 10016, USA., Voloshyna I; Laura and Isaac Perlmutter Cancer Center and Department of Pathology, New York University Grossman School of Medicine, New York, New York, 10016, USA., Kim J; Laura and Isaac Perlmutter Cancer Center and Department of Pathology, New York University Grossman School of Medicine, New York, New York, 10016, USA., Tardio E; Laura and Isaac Perlmutter Cancer Center and Department of Pathology, New York University Grossman School of Medicine, New York, New York, 10016, USA., Velmurugu Y; Laura and Isaac Perlmutter Cancer Center and Department of Pathology, New York University Grossman School of Medicine, New York, New York, 10016, USA., Nyovanie S; Laura and Isaac Perlmutter Cancer Center and Department of Pathology, New York University Grossman School of Medicine, New York, New York, 10016, USA., Valeria Calderon A; Laura and Isaac Perlmutter Cancer Center and Department of Pathology, New York University Grossman School of Medicine, New York, New York, 10016, USA., Dibba F; Laura and Isaac Perlmutter Cancer Center and Department of Pathology, New York University Grossman School of Medicine, New York, New York, 10016, USA., Stanzin I; Laura and Isaac Perlmutter Cancer Center and Department of Pathology, New York University Grossman School of Medicine, New York, New York, 10016, USA., Samanovic MI; NYU Langone Vaccine Center, Department of Medicine, NYU Grossman School of Medicine, New York, New York, USA., Raut P; Genentech, Inc., South San Francisco, California, USA., Raposo C; F. Hoffmann-La Roche Ltd, Basel, Switzerland., Priest J; Genentech, Inc., South San Francisco, California, USA., Cabatingan M; Genentech, Inc., South San Francisco, California, USA., Winger RC; Genentech, Inc., South San Francisco, California, USA., Mulligan MJ; NYU Langone Vaccine Center, Department of Medicine, NYU Grossman School of Medicine, New York, New York, USA., Patskovsky Y; Laura and Isaac Perlmutter Cancer Center and Department of Pathology, New York University Grossman School of Medicine, New York, New York, 10016, USA., Silverman GJ; Division of Rheumatology, Department of Medicine, New York University Grossman School of Medicine, New York, New York, 10016, USA., Krogsgaard M; Laura and Isaac Perlmutter Cancer Center and Department of Pathology, New York University Grossman School of Medicine, New York, New York, 10016, USA.

Publikováno v: Annals of clinical and translational neurology [Ann Clin Transl Neurol] 2022 Oct; Vol. 9 (10), pp. 1643-1659. Date of Electronic Publication: 2022 Sep 27.